Share on LinkedInShare on LinkedIn

ARTICLE · 05 OCTOBER 2026

OSHA Highlights Workplace Opioid Overdose Preparedness

Jackson Lewis P.C.
Jackson Lewis P.C.
Contributor
Jackson Lewis P.C.

Jackson Lewis P.C.

Focused on labor and employment law since 1958, Jackson Lewis P.C.’s 950+ attorneys located in...

View firm profile
Explore more from Jackson Lewis P.C.

Federal guidance from OSHA now encourages employers to stock opioid reversal medications like naloxone in the workplace and train employees to recognize and respond to overdose emergencies. While the recommendations don't create new compliance obligations, some states are already mandating these preparations, raising questions about how organizations should adapt their emergency response protocols.

United StatesEmployment and HR

Employers have new federal guidance to help them recognize and respond to opioid overdoses at work. On Sept. 24, 2026, the Occupational Safety and Health Administration (OSHA) released a fact sheet supporting the Trump Administration’s Great American Recovery Initiative.

The fact sheet, “Opioid Overdose Rescue with Reversal Medications,” encourages employers to consider keeping medications such as naloxone or nalmefene available in the workplace. It does not impose new compliance requirements.

Preparing the Workplace

OSHA’s recommendations address both access to medications and employee readiness:

  • Placement and storage: Keep medications in visible, accessible locations, such as alongside automated external defibrillators or first aid kits, and follow product storage instructions.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from